FY25 guidance 25 November 2025 | 2:22AM HKT Equity Research JD Health International (6618.HK): Internet Trip takeaways: continued share gain across categories, drugs momentum to continue; Buy We hosted JD Health (JDH) Investor Relations team with investors on Nov 24 in Beijing during our China internet trip, where investors' key focus and our takeaways were centered around: 1) FY25 revenue and profit guidance; 2) recent trend by product category; 3) thoughts and investments on O2O initiatives; 4) update on ...